Sign up to save your podcasts
Or
Share Legislation Could Further Limit Discriminatory Drug Cost Controls…
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Legislation Could Further Limit Discriminatory Drug Cost Controls…
This week, Jeremy is joined by Sara Van Geertruyden, executive director of the Partnership to Improve Patient Care, to talk about legislation moving through Congress that would extend prohibitions on the use of quality adjusted life years (QALYs) in drug pricing and access decisions.
Read the National Council on Disabilities report finding QUALYs to be discriminatory at https://ncd.gov/sites/default/files/NCD_Quality_Adjusted_Life_Report_508.pdf
This episode is brought to you by The ALS Association in partnership with CitizenRacecar.
View all episodes
By ALS Association
4.7
4949 ratings
This week, Jeremy is joined by Sara Van Geertruyden, executive director of the Partnership to Improve Patient Care, to talk about legislation moving through Congress that would extend prohibitions on the use of quality adjusted life years (QALYs) in drug pricing and access decisions.
Read the National Council on Disabilities report finding QUALYs to be discriminatory at https://ncd.gov/sites/default/files/NCD_Quality_Adjusted_Life_Report_508.pdf
This episode is brought to you by The ALS Association in partnership with CitizenRacecar.